http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112121181-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32e2f35c1c59766b889501192af31db3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6486 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 |
| filingDate | 2020-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95e2dc570ababb7065481d1b823a47d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b9ccb0e6e13b2963ee35360c7cfba28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8ec2bf4f8312c8a5f56efc63262853e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83c6d2ca2b3419d24d5b943348da6ec4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58dd4456687d9fa19d367ab3f886b42f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_766d4eb7d8a21e72ee0a874735d8e1ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa5df3302eae12e97ea2f4aef33a0a88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f995346065ebdc90e58bb5537d0f7274 |
| publicationDate | 2020-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112121181-A |
| titleOfInvention | A method for evaluating the efficacy of health care products to enhance immunity |
| abstract | The invention belongs to the technical field of detection. The invention discloses a method for evaluating the immunity-enhancing efficacy of health care products, which comprises using zebrafish to set up a model control group and a test product group, taking fluorescence pictures, analyzing the fluorescence intensity S of macrophages in the tail of the zebrafish, and using the fluorescence intensity S to calculate Enhance immunity. The method does not need to explore the concentration of the reagents, and the reagents used are relatively stable, which can reduce the experimental steps; the experimental period of the zebrafish enhanced immunity model is shorter than that of the mouse experiment, only 24 hours; because the zebrafish has low feeding cost and small volume , The characteristics of short development cycle and high number of single eggs can be evaluated for multiple samples at the same time; the sum of fluorescence intensity S of macrophages in the tail of zebrafish is used as the judgment standard, as long as the zebrafish in the test group is higher than the model control group. The significant difference can be judged to have the effect of enhancing immunity; the used inducer vinorelbine is a common chemotherapeutic drug with less toxic effect. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113583941-A |
| priorityDate | 2020-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.